Observational studyKidney3602026
Changes in Depressive Symptoms Pre- and Post-Kidney Transplantation.
Observational study in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
key pointsDepressive symptoms increased modestly during the first 4 years after kidney transplant but remained below the threshold for clinical depression. Post-kidney transplant Center for Epidemiologic Studies Depression scores improved in recipients with high pre-kidney transplant depressive symptoms. Clinicians should counsel patients on the potential mental health implications of kidney transplant and individualize care decisions accordingly.
backgroundDepressive symptoms are common in patients with ESKD and may persist after stopping dialysis because of challenges post-kidney transplant (KT) despite clinical benefits. We sought to assess changes in depressive symptoms pre- and post-KT.
methodsWe leveraged a multicenter prospective cohort of 4661 adult (aged ≥18) potential KT candidates and 1215 recipients (2008-2025). Participants reported depressive symptoms via the Center for Epidemiologic Studies Depression (CES-D) scale (range 0-60, high depressive symptoms ≥16) at evaluation, KT, and post-KT. We used linear mixed-effect models to estimate post-KT trajectories of CES-D scores overall and by characteristics at KT admission.
resultsNineteen percentage of potential candidates at evaluation and 15% of recipients at admission had depressive symptoms; 46% and 38%, respectively, were non-Hispanic Black. Over the first 4 years post-KT, depressive symptoms slightly worsened (slope=0.4 points/yr, 95% confidence interval [CI], 0.3 to 0.6) but remained below the threshold for clinical depression. Post-KT, CES-D score change differed by pre-KT high depressive symptoms score (difference=-1.2 points/yr, 95% CI, -1.8 to -0.6). Specifically, post-KT depressive symptoms were 0.7 points/yr lower (95% CI, -1.2 to -0.1) among recipients with pre-KT high depressive symptoms and 0.5 points/yr higher (95% CI, 0.3 to 0.7) among those without. CES-D score change also differed by preemptive KT status (difference=-0.6 points/yr, 95% CI, -1.0 to -0.1, non-preemptive versus preemptive).
conclusionsDepressive symptoms worsened slightly over the first 4 years post-KT but remained below the threshold for clinical depression. Notably, post-KT CES-D scores decreased in recipients with high pre-KT depressive symptoms. Clinicians should discuss the mental health impact of KT with patients and tailor care decisions to individual needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.